Mitochondria-targeted antioxidant supplementation improves 8 km time trial performance in middle-aged trained male cyclists

Background Exercise increases skeletal muscle reactive oxygen species (ROS) production, which may contribute to the onset of muscular fatigue and impair athletic performance. Mitochondria-targeted antioxidants such as MitoQ, which contains a ubiquinone moiety and is targeted to mitochondria through...

Full description

Bibliographic Details
Main Authors: S. C. Broome, A. J. Braakhuis, C. J. Mitchell, T. L. Merry
Format: Article
Language:English
Published: Taylor & Francis Group 2021-08-01
Series:Journal of the International Society of Sports Nutrition
Subjects:
Online Access:http://dx.doi.org/10.1186/s12970-021-00454-0
_version_ 1797684947855605760
author S. C. Broome
A. J. Braakhuis
C. J. Mitchell
T. L. Merry
author_facet S. C. Broome
A. J. Braakhuis
C. J. Mitchell
T. L. Merry
author_sort S. C. Broome
collection DOAJ
description Background Exercise increases skeletal muscle reactive oxygen species (ROS) production, which may contribute to the onset of muscular fatigue and impair athletic performance. Mitochondria-targeted antioxidants such as MitoQ, which contains a ubiquinone moiety and is targeted to mitochondria through the addition of a lipophilic triphenylphosphonium cation, are becoming popular amongst active individuals as they are designed to accumulate within mitochondria and may provide targeted protection against exercise-induced oxidative stress. However, the effect of MitoQ supplementation on cycling performance is currently unknown. Here, we investigate whether MitoQ supplementation can improve cycling performance measured as time to complete an 8 km time trial. Method In a randomized, double-blind, placebo-controlled crossover study, 19 middle-aged (age: 44 ± 4 years) recreationally trained (VO2peak: 58.5 ± 6.2 ml·kg− 1·min− 1, distance cycled per week during 6 months prior to study enrollment: 158.3 ± 58.4 km) male cyclists completed 45 min cycling at 70% VO2peak followed by an 8 km time trial after 28 days of supplementation with MitoQ (20 mg·day− 1) and a placebo. Free F2-isoprostanes were measured in plasma samples collected at rest, after 45 min cycling at 70% VO2peak and after completion of the time trial. Respiratory gases and measures of rating of perceived exertion (RPE) were also collected. Results Mean completion time for the time trial was 1.3% faster with MitoQ (12.91 ± 0.94 min) compared to placebo (13.09 ± 0.95 min, p = 0.04, 95% CI [0.05, 2.64], d = 0.2). There was no difference in RPE during the time trial between conditions (p = 0.82) despite there being a 4.4% increase in average power output during the time trial following MitoQ supplementation compared to placebo (placebo; 270 ± 51 W, MitoQ; 280 ± 53 W, p = 0.04, 95% CI [0.49, 8.22], d = 0.2). Plasma F2-isoprostanes were lower on completion of the time trial following MitoQ supplementation (35.89 ± 13.6 pg·ml− 1) compared to placebo (44.7 ± 16.9 pg·ml− 1 p = 0.03). Conclusion These data suggest that MitoQ supplementation may be an effective nutritional strategy to attenuate exercise-induced increases in oxidative damage to lipids and improve cycling performance.
first_indexed 2024-03-12T00:38:18Z
format Article
id doaj.art-79f0649356c44b3c9b1182cda7a417a1
institution Directory Open Access Journal
issn 1550-2783
language English
last_indexed 2024-03-12T00:38:18Z
publishDate 2021-08-01
publisher Taylor & Francis Group
record_format Article
series Journal of the International Society of Sports Nutrition
spelling doaj.art-79f0649356c44b3c9b1182cda7a417a12023-09-15T09:19:32ZengTaylor & Francis GroupJournal of the International Society of Sports Nutrition1550-27832021-08-0118110.1186/s12970-021-00454-012130263Mitochondria-targeted antioxidant supplementation improves 8 km time trial performance in middle-aged trained male cyclistsS. C. Broome0A. J. Braakhuis1C. J. Mitchell2T. L. Merry3Discipline of Nutrition, School of Medical SciencesDiscipline of Nutrition, School of Medical SciencesSchool of KinesiologyDiscipline of Nutrition, School of Medical SciencesBackground Exercise increases skeletal muscle reactive oxygen species (ROS) production, which may contribute to the onset of muscular fatigue and impair athletic performance. Mitochondria-targeted antioxidants such as MitoQ, which contains a ubiquinone moiety and is targeted to mitochondria through the addition of a lipophilic triphenylphosphonium cation, are becoming popular amongst active individuals as they are designed to accumulate within mitochondria and may provide targeted protection against exercise-induced oxidative stress. However, the effect of MitoQ supplementation on cycling performance is currently unknown. Here, we investigate whether MitoQ supplementation can improve cycling performance measured as time to complete an 8 km time trial. Method In a randomized, double-blind, placebo-controlled crossover study, 19 middle-aged (age: 44 ± 4 years) recreationally trained (VO2peak: 58.5 ± 6.2 ml·kg− 1·min− 1, distance cycled per week during 6 months prior to study enrollment: 158.3 ± 58.4 km) male cyclists completed 45 min cycling at 70% VO2peak followed by an 8 km time trial after 28 days of supplementation with MitoQ (20 mg·day− 1) and a placebo. Free F2-isoprostanes were measured in plasma samples collected at rest, after 45 min cycling at 70% VO2peak and after completion of the time trial. Respiratory gases and measures of rating of perceived exertion (RPE) were also collected. Results Mean completion time for the time trial was 1.3% faster with MitoQ (12.91 ± 0.94 min) compared to placebo (13.09 ± 0.95 min, p = 0.04, 95% CI [0.05, 2.64], d = 0.2). There was no difference in RPE during the time trial between conditions (p = 0.82) despite there being a 4.4% increase in average power output during the time trial following MitoQ supplementation compared to placebo (placebo; 270 ± 51 W, MitoQ; 280 ± 53 W, p = 0.04, 95% CI [0.49, 8.22], d = 0.2). Plasma F2-isoprostanes were lower on completion of the time trial following MitoQ supplementation (35.89 ± 13.6 pg·ml− 1) compared to placebo (44.7 ± 16.9 pg·ml− 1 p = 0.03). Conclusion These data suggest that MitoQ supplementation may be an effective nutritional strategy to attenuate exercise-induced increases in oxidative damage to lipids and improve cycling performance.http://dx.doi.org/10.1186/s12970-021-00454-0rosmitochondriaantioxidantperformanceoxidative stress
spellingShingle S. C. Broome
A. J. Braakhuis
C. J. Mitchell
T. L. Merry
Mitochondria-targeted antioxidant supplementation improves 8 km time trial performance in middle-aged trained male cyclists
Journal of the International Society of Sports Nutrition
ros
mitochondria
antioxidant
performance
oxidative stress
title Mitochondria-targeted antioxidant supplementation improves 8 km time trial performance in middle-aged trained male cyclists
title_full Mitochondria-targeted antioxidant supplementation improves 8 km time trial performance in middle-aged trained male cyclists
title_fullStr Mitochondria-targeted antioxidant supplementation improves 8 km time trial performance in middle-aged trained male cyclists
title_full_unstemmed Mitochondria-targeted antioxidant supplementation improves 8 km time trial performance in middle-aged trained male cyclists
title_short Mitochondria-targeted antioxidant supplementation improves 8 km time trial performance in middle-aged trained male cyclists
title_sort mitochondria targeted antioxidant supplementation improves 8 km time trial performance in middle aged trained male cyclists
topic ros
mitochondria
antioxidant
performance
oxidative stress
url http://dx.doi.org/10.1186/s12970-021-00454-0
work_keys_str_mv AT scbroome mitochondriatargetedantioxidantsupplementationimproves8kmtimetrialperformanceinmiddleagedtrainedmalecyclists
AT ajbraakhuis mitochondriatargetedantioxidantsupplementationimproves8kmtimetrialperformanceinmiddleagedtrainedmalecyclists
AT cjmitchell mitochondriatargetedantioxidantsupplementationimproves8kmtimetrialperformanceinmiddleagedtrainedmalecyclists
AT tlmerry mitochondriatargetedantioxidantsupplementationimproves8kmtimetrialperformanceinmiddleagedtrainedmalecyclists